<DOC>
	<DOCNO>NCT01477034</DOCNO>
	<brief_summary>Chronic , low-grade adipose tissue inflammation major risk factor type 2 diabetes mellitus . The cause adipose tissue inflammation remain largely unclear . We hypothesize vitamin D deficiency predispose individual development adipose tissue inflammation , treatment vitamin D deficient subject high dose vitamin D reduce adipose tissue inflammation .</brief_summary>
	<brief_title>Vitamin D Adipose Tissue Inflammation</brief_title>
	<detailed_description>The objective project investigate whether vitamin D modulate chronic low-grade adipose tissue inflammation overweight obese , vitamin D deficient men woman . Obesity associate insulin resistance increase risk type 2 diabetes mellitus . Numerous study , mostly conduct mouse model obesity , strongly suggest chronic low-grade inflammation adipose tissue major mechanism increase adiposity link insulin resistance . Adipose tissue inflammation may therefore promise therapeutic target reduce insulin resistance risk type 2 diabetes mellitus obese individual . Based several line evidence , hypothesize vitamin D environmental factor affect course inflammatory response tissue body , include adipose tissue . In previous study , find circulate plasma concentration 25-hydroxy vitamin D ( 25-OH-D ) primary degradation product 24,25-dihydroxy vitamin D ( 24,25-OH2-D ) significantly associate adipose tissue expression adiponectin negatively TNF-alpha , even adjust body mass index . Because previous study cross-sectional , critical complete intervention study human determine whether observe association vitamin D level adipose tissue inflammation causal . The objective pilot study therefore collect relevant preliminary data , begin exploration mechanism underlie association intestinal permeability . Increased intestinal permeability may contribute chronic low-grade inflammation signal vitamin D receptor play important role maintenance intestinal integrity . We assess whether normalization vitamin D status associate change intestinal permeability .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Age : 1865 year ; BMI â‰¥25 kg/m2 ; Plasma 25OHvitamin D 7 20 ng/mL Weight stable within 10 pound 6 month prior enter study , within 30 pound lifetime maximum weight ( exclude pregnancy ) ; Ability admit ~6.5 hour three occasion FHCRC Prevention Center , Ability provide inform write consent ; Willingness take vitamin D3 capsule daily 6 month Chronic disease thyroid disease , liver disease , kidney disease ; Diabetes mellitus , fast glucose &gt; 125 mg/dL ; Chronic inflammatory condition autoimmune disease inflammatory bowel disease ; Malabsorption syndrome ( untreated celiac disease ; condition stomach intestinal resection ) ; Current recent ( within one month ) chronic intake medication likely interfere study endpoint [ ( insulin , antidiabetic , anabolic steroid , glucocorticosteroids , statin , blood thinner ( warfarin , aspirin ) , nonsteroidal antiinflammatory drug ( daily ) ] ; Current recent ( within 3 month ) intake vitamin D excess 600 IU/day ; Anemia , recent history ( within 3 month ) anemia ; recent ( within 3 month ) blood donation ; recent ( within 3 month ) participation another study involve blood draw ; plan participate research involve blood draw study period ; Pregnancy last 6 month , plan become pregnant study period , current breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>Obesity</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Low-grade , chronic inflammation</keyword>
	<keyword>Adipose tissue inflammation</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Intestinal permeability</keyword>
</DOC>